Category: Uncategorized

CVS’ $315 MILLION OPIOID SETTLEMENT: COMPLIANCE IS BECOMING PART OF THE PHARMACY OPERATING MODEL

14/10/2026 Published by HealthBiz

Key Development CVS Health has agreed to pay $315 million to resolve U.S. Department of Justice allegations that its pharmacies... Read more

Tags: #Global Trends

J&J BEATS EXPECTATIONS BUT MEDTECH SLOWS: GEOPOLITICS IS BECOMING A NEW VARIABLE IN HEALTHCARE GROWTH

14/10/2026 Published by HealthBiz

Key Development Johnson & Johnson delivered another headline beat in Q3 2026, reporting approximately $25.4 billion in revenue, up 5.9%,... Read more

Category: Uncategorized

Tags: #Global Trends

BIONTECH’S BNT113 MISSES PFS: THE REAL TEST IS WHETHER MRNA CAN DELIVER SURVIVAL BEYOND KEYTRUDA

14/10/2026 Published by HealthBiz

Key Development BioNTech has encountered an important test of its effort to extend mRNA technology from vaccines into oncology. In... Read more

Category: Uncategorized

Tags: #Global Trends

ROCHE PUTS UP TO $1.16 BILLION BEHIND ALK7 RNAI: THE OBESITY RACE IS SHIFTING FROM “HOW MUCH WEIGHT?” TO “WHAT KIND OF WEIGHT?”

14/10/2026 Published by HealthBiz

Key Development Roche has opened another front in obesity, licensing an investigational ALK7-targeting RNA interference therapy from Rona Therapeutics in... Read more

Category: Uncategorized

Tags: #Global Trends

BIMZELX TOPS PHARMA AD SPENDING: THE IMMUNOLOGY RACE IS SHIFTING FROM “WHO HAS THE BETTER DRUG” TO “WHO CAN ACTIVATE DEMAND FASTER”

13/10/2026 Published by HealthBiz

Key Development UCB's Bimzelx became the highest-spending pharmaceutical brand in U.S. cross-platform television advertising in September 2026, with an estimated... Read more

Category: Uncategorized

Tags: #Global Trends